- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar forges deal for China
MRI salesMRI manufacturer Fonar hasentered into a joint venture agreement to sell its scanners inthe People's Republic of China, Dow Jones News Service reportedthis month. Fonar joined with Chinese corporation Qingdao YuanTong and Mayer Medical Ltd. of
MRI salesMRI manufacturer Fonar hasentered into a joint venture agreement to sell its scanners inthe People's Republic of China, Dow Jones News Service reportedthis month. Fonar joined with Chinese corporation Qingdao YuanTong and Mayer Medical Ltd. of Hong Kong to market, distributeand finance MRI scanners.
The companies have set a minimum goal of $16 million in salesand service revenue for Fonar by the end of 1996. Fonar is basedin Melville, NY.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
